Updated results from the phase 3 MANIFEST-2 study of pelabresib in combination with ruxolitinib for Janus kinase inhibitor-naive patients with myelofibrosis Meeting Abstract
| Authors: | Mascarenhas, J. O.; Grosicki, S.; Chraniuk, D.; Abruzzese, E.; Bose, P.; Gerds, A. T.; Vannucchi, A. M.; Palandri, F.; Lee, S. E.; Gupta, V.; Lucchesi, A.; Oh, S.; Kuykendall, A. T.; Patriarca, A.; Alvarez-Larran, A.; Mesa, R.; Kiladjian, J. J.; Talpaz, M.; Harris, M.; Kays, S. K.; Li, Q.; Brown, B.; Jegg, A. M.; Harrison, C.; Rampal, R. |
| Abstract Title: | Updated results from the phase 3 MANIFEST-2 study of pelabresib in combination with ruxolitinib for Janus kinase inhibitor-naive patients with myelofibrosis |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 3178 |
| End Page: | 3180 |
| Language: | English |
| ACCESSION: | WOS:001412581600034 |
| DOI: | 10.1182/blood-2024-193193 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
